Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Higher Female Mortality After Bypass Surgery Explained

By HospiMedica staff writers
Posted on 26 Jan 2007
A new study suggests that transfusions of donated blood may be a reason for the excess mortality among women after coronary artery bypass graft (CABG) surgery.

Researchers at the University of Michigan (Ann Arbor, USA) studied 9,218 Michigan (USA) Medicare beneficiaries who had CABG surgery from July 1, 1997 through September 22, 1998. More...
Of these patients, 74.8% received an allogeneic blood transfusion during the procedure. Transfusions were more common in women than in men (88.2% versus 66.7%), and 14.6% of those who received donated blood had a subsequent infection, compared with 4.9% of those who did not. Patients who received a transfusion were 5.6 times as likely to die within 100 days of the surgery as those who did not receive a transfusion.

There was a statistically significant dose-response relationship between the number of units of whole blood or packed red cells used and the prevalence of infection. Women had a 13.9% unadjusted risk of death, but when the researchers adjusted for transfusions, it fell to 0.6%, which was no longer significantly different from men. The researchers therefore suggest that the key factor appears to be foreign leukocytes, which can act as an immune suppressant, rendering the patient more susceptible to infection. The study was reported in the December 2006 issue of the American Heart Journal.

"There is recent evidence suggesting that the duration of storage of transfused red blood cells increases both in-hospital and post-discharge mortality risk, but we were unable to determine details regarding blood storage in this database,” wrote Dr. Mary Rogers, Ph.D., and colleagues of the University of Michigan department of internal medicine. "It is possible that either the presence of leukocytes or extended storage of blood components, or both, affect mortality risk.”



Related Links:
University of Michigan

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.